Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 9.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Headquarters
One Amgen Center Drive
Thousand Oaks; California; Map
Postal Code: 91320-1799
Tel: (1)805-447-
Fax: (1)805-447-
Email: @amgen.com
Website: http://www.amgen.com

Full name: Amgen Inc. (Amgen Inc.)

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 1600026
ISIN: US0311621009
Incorporation Date: 1980

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing | Electromedical and Electrotherapeutic Apparatus Manufacturing

Main Products

Aranesp (darbepoetin alfa), Enbrel(etanercept), EPOGEN (Epoetin alfa), Neulasta (pegfilgrastim), NEUPOGEN (Filgrastim), Nplate (romiplostim), Prolia (denosumab), Sensipar (cinacalcet), Vectibix (panitumumab), XGEVA (denosumab)

More

Company Description

Amgen discovers, develops, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing novel medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses.

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

Key Executives

President
More

Competitors - Hong Kong

N | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 9.95 USD
Payment methods include:
USD 9.95
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest